The country has so far relied almost solely on homegrown medicines and vaccines to shore up immunity and treat COVID patients. 

With its new financing, TransVoyant will scale to reach new customers and expand its platform’s use cases.

The shortages are a reminder that volatile turns in demand and supply that have marked the pandemic are still undercutting some sectors.

Though the vast majority of the country’s population has already been vaccinated, Chinese authorities have relied on locally developed shots like those from state-backed Sinopharm and Sinovac.

The proposal follows similar announcements on November 2 from the two largest U.S. pharmacy chains, CVS Health and Walgreen Co,

Some of Wall Street’s biggest companies have been in the vanguard of those pulling employees back into the office as concerns about the pandemic have begun fading.

Nearly 8% of stock perishes or is discarded and, in fact, 4.3% of stock spoils in the supply chain before it even reaches the shelf.

Prescriptions for Mounjaro have grown rapidly since it was approved in the U.S. in May, and a shortage in a competing drug may drive more patients to Lilly’s medicine.

Creating resilient and agile supply chains requires leveragING economies of scale when working with suppliers while minimizing risk, disruptions and shortages